209 related articles for article (PubMed ID: 17885513)
21. Inflammation and endothelial dysfunction as therapeutic targets in patients with heart failure.
Tousoulis D; Charakida M; Stefanadis C
Int J Cardiol; 2005 Apr; 100(3):347-53. PubMed ID: 15837076
[TBL] [Abstract][Full Text] [Related]
22. Aminothiol redox alterations in patients with chronic heart failure of ischaemic or non-ischaemic origin.
Campolo J; Caruso R; De Maria R; Parolini M; Oliva F; Roubina E; Cighetti G; Frigerio M; Vitali E; Parodi O
J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1024-8. PubMed ID: 18163014
[TBL] [Abstract][Full Text] [Related]
23. c-Jun N-terminal kinase 2 deficiency protects against hypercholesterolemia-induced endothelial dysfunction and oxidative stress.
Osto E; Matter CM; Kouroedov A; Malinski T; Bachschmid M; Camici GG; Kilic U; Stallmach T; Boren J; Iliceto S; Lüscher TF; Cosentino F
Circulation; 2008 Nov; 118(20):2073-80. PubMed ID: 18955669
[TBL] [Abstract][Full Text] [Related]
24. Oxidative stress and endothelial dysfunction.
Muller G; Goettsch C; Morawietz H
Hamostaseologie; 2007 Feb; 27(1):5-12. PubMed ID: 17279271
[TBL] [Abstract][Full Text] [Related]
25. Nitric oxide signaling in the cardiovascular system: implications for heart failure.
Saraiva RM; Hare JM
Curr Opin Cardiol; 2006 May; 21(3):221-8. PubMed ID: 16601461
[TBL] [Abstract][Full Text] [Related]
26. [Physiopathologic effects of nitric oxide and their relationship with oxidative stress].
Carrizo PH; Dubin M; Stoppani AO
Medicina (B Aires); 1998; 58(4):367-73. PubMed ID: 9816698
[TBL] [Abstract][Full Text] [Related]
27. Oxidative stress induces myeloperoxidase expression in endocardial endothelial cells from patients with chronic heart failure.
La Rocca G; Di Stefano A; Eleuteri E; Anzalone R; Magno F; Corrao S; Loria T; Martorana A; Di Gangi C; Colombo M; Sansone F; Patanè F; Farina F; Rinaldi M; Cappello F; Giannuzzi P; Zummo G
Basic Res Cardiol; 2009 May; 104(3):307-20. PubMed ID: 19030913
[TBL] [Abstract][Full Text] [Related]
28. Effect of alpha-lipoic acid on LPS-induced oxidative stress in the heart.
Goraca A; Piechota A; Huk-Kolega H
J Physiol Pharmacol; 2009 Mar; 60(1):61-8. PubMed ID: 19439808
[TBL] [Abstract][Full Text] [Related]
29. Consensus meeting on "Relevance of parenteral vitamin C in acute endothelial dependent pathophysiological conditions (EDPC)".
Lehr HA; Germann G; McGregor GP; Migeod F; Roesen P; Tanaka H; Uhlig C; Biesalski HK
Eur J Med Res; 2006 Dec; 11(12):516-26. PubMed ID: 17182364
[TBL] [Abstract][Full Text] [Related]
30. Blockade of nitroxidative stress by roasted licorice extracts in high glucose-exposed endothelial cells.
Choi YJ; Lim SS; Jung JY; Choi JS; Kim JK; Han SJ; Kang YH
J Cardiovasc Pharmacol; 2008 Oct; 52(4):344-54. PubMed ID: 18841076
[TBL] [Abstract][Full Text] [Related]
31. Uncoupled endothelial nitric oxide synthase and oxidative stress in a rat model of pregnancy-induced hypertension.
Mitchell BM; Cook LG; Danchuk S; Puschett JB
Am J Hypertens; 2007 Dec; 20(12):1297-304. PubMed ID: 18047920
[TBL] [Abstract][Full Text] [Related]
32. AMPKalpha1 regulates the antioxidant status of vascular endothelial cells.
Colombo SL; Moncada S
Biochem J; 2009 Jun; 421(2):163-9. PubMed ID: 19442239
[TBL] [Abstract][Full Text] [Related]
33. Heart failure--new insights.
Blum A
Isr Med Assoc J; 2009 Feb; 11(2):105-11. PubMed ID: 19432040
[TBL] [Abstract][Full Text] [Related]
34. Biochemical mechanisms of oxidative liver cell injury.
Orrenius S; Nicotera P
Bull Eur Physiopathol Respir; 1987; 23(4):291-5. PubMed ID: 3690016
[TBL] [Abstract][Full Text] [Related]
35. Indoxyl sulfate inhibits nitric oxide production and cell viability by inducing oxidative stress in vascular endothelial cells.
Tumur Z; Niwa T
Am J Nephrol; 2009; 29(6):551-7. PubMed ID: 19129694
[TBL] [Abstract][Full Text] [Related]
36. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase 2-selective and nonselective nonsteroidal anti-inflammatory drugs induce oxidative stress by up-regulating vascular NADPH oxidases.
Li H; Hortmann M; Daiber A; Oelze M; Ostad MA; Schwarz PM; Xu H; Xia N; Kleschyov AL; Mang C; Warnholtz A; Münzel T; Förstermann U
J Pharmacol Exp Ther; 2008 Sep; 326(3):745-53. PubMed ID: 18550689
[TBL] [Abstract][Full Text] [Related]
38. [Oxidative stress in haemostasis].
Nowak P; Olas B; Wachowicz B
Postepy Biochem; 2010; 56(3):239-47. PubMed ID: 21117311
[TBL] [Abstract][Full Text] [Related]
39. Oxidant stress mechanisms in heart failure.
Chandra M; Surendra K; Kapoor RK; Ghatak A; Kaur G; Pandey NR; Misra MK
Boll Chim Farm; 2000; 139(3):149-52. PubMed ID: 10961027
[TBL] [Abstract][Full Text] [Related]
40. [New pharmacological approaches in heart failure: should we treat the endothelium?].
Richard V; Vercauteren M; Gomez E; Thuillez C
Therapie; 2009; 64(2):93-100. PubMed ID: 19664402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
